Guardant Health Inc (GH) CEO Helmy Eltoukhy Sold $5.7 million of Shares

In This Article:

- By insider

CEO of Guardant Health Inc (GH) Helmy Eltoukhy sold 78,660 shares of GH on 05/14/2019 at an average price of $72.34 a share. The total sale was $5.7 million.

Guardant Health Inc has a market cap of $6.67 billion; its shares were traded at around $76.60 with and P/S ratio of 58.81.


CEO Recent Trades:

  • CEO Helmy Eltoukhy sold 78,660 shares of GH stock on 05/14/2019 at the average price of $72.34. The price of the stock has increased by 5.89% since.

  • CEO Helmy Eltoukhy sold 131,340 shares of GH stock on 05/01/2019 at the average price of $65.32. The price of the stock has increased by 17.27% since.

  • CEO Helmy Eltoukhy sold 90,000 shares of GH stock on 04/22/2019 at the average price of $65.28. The price of the stock has increased by 17.34% since.

CFO Recent Trades:

  • CFO Derek A Bertocci sold 18,562 shares of GH stock on 05/10/2019 at the average price of $76.3. The price of the stock has increased by 0.39% since.

Directors and Officers Recent Trades:

  • Chief Legal Officer Michael J Wiley sold 80,000 shares of GH stock on 05/08/2019 at the average price of $65.96. The price of the stock has increased by 16.13% since.

  • Director Ian T Clark sold 2,690 shares of GH stock on 05/03/2019 at the average price of $65.91. The price of the stock has increased by 16.22% since.

  • Chief Medical Officer Richard B. Lanman sold 3,842 shares of GH stock on 05/01/2019 at the average price of $64.84. The price of the stock has increased by 18.14% since.

  • Director Ian T Clark sold 538 shares of GH stock on 04/25/2019 at the average price of $65.11. The price of the stock has increased by 17.65% since.

  • Chairman, President and COO Amirali Talasaz sold 117,540 shares of GH stock on 04/24/2019 at the average price of $66.69. The price of the stock has increased by 14.86% since.

For the complete insider trading history of GH, click here

.This article first appeared on GuruFocus.